Literature DB >> 2005450

Lung thallium-201 uptake during exercise emission computed tomography.

C Kurata1, K Tawarahara, T Taguchi, K Sakata, N Yamazaki, Y Naitoh.   

Abstract

To test whether the analysis of lung uptake is worth adding to the interpretation of exercise thallium-201 (201TI) emission computed tomography (ECT), a lung/heart ratio of 201TI uptake was measured from an anterior image during ECT in 25 clinically normal (Group 1), 91 angiographically normal (Group 2), and 265 subjects with coronary artery disease (Group 3). The mean +2 s.d. of ratios in Groups 1 and 2 were the same (0.37). In Group 3, 80 subjects (30%) with increased ratios (greater than 0.37) had higher frequencies of prior infarction and multi-vessel disease, more severe left ventricular dysfunction, and 201TI defects than 185 subjects with normal ratios. Subjects with markedly increased ratios (greater than 0.45) had three-vessel disease more frequently than those with slightly or moderately increased ratios (67% versus 14% or 35%). Thus the measurement of lung/heart ratios may provide information regarding the severity of coronary artery disease and should be added to the routine interpretation of exercise ECT.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2005450

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  12 in total

1.  Diagnostic value of Tl-201 lung uptake is dependent on measurement method.

Authors:  A Hitzel; A Manrique; A Cribier; P Véra
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

Review 2.  The use of thallium-201 lung/heart ratios.

Authors:  S Mahmood; J R Buscombe; P J Ell
Journal:  Eur J Nucl Med       Date:  1992

3.  Myocardial perfusion imaging with adenosine triphosphate predicts the rate of cardiovascular events.

Authors:  Isabel Coma-Canella; Jorge Palazuelos; Nieves Bravo; María José García Velloso
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

4.  Identification of advanced coronary artery disease with exercise myocardial perfusion imaging: the clinical value of a novel approach for assessing lung thallium-201 uptake.

Authors:  Efstratios Moralidis; Tryfon Spyridonidis; Georgios Arsos; Constantinos Anagnostopoulos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-23       Impact factor: 9.236

5.  Quantification of left ventricular size on exercise thallium-201 single-photon emission tomography.

Authors:  C Kurata; Y Wakabayashi; S Shouda; T Mikami; K Tawarahara
Journal:  Eur J Nucl Med       Date:  1996-07

Review 6.  What is the current status of quantification and nuclear medicine in cardiology?

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1996-07

7.  Long-term prognostic value of early poststress (99m)Tc-tetrofosmin lung uptake during exercise (SPECT) myocardial perfusion imaging.

Authors:  Panagiotis Georgoulias; Ioannis Tsougos; Varvara Valotassiou; Chara Tzavara; Petros Xaplanteris; Nikolaos Demakopoulos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-17       Impact factor: 9.236

8.  Noninvasive identification of left main and three-vessel coronary artery disease by thallium-201 single photon emission computed tomography during adenosine infusion.

Authors:  Y Takeishi; J Chiba; S Abe; A Komatani; K Takahashi; H Tomoike
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

9.  Abnormal heart rate recovery immediately after treadmill testing: correlation with clinical, exercise testing, and myocardial perfusion parameters.

Authors:  Panagiotis Georgoulias; Alexandros Orfanakis; Nikolaos Demakopoulos; Petros Xaplanteris; Georgios Mortzos; Panos Vardas; Nikolaos Karkavitsas
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

10.  Dipyridamole-induced abnormal Tl-201 lung uptake in patients with normal myocardial perfusion: a marker of increased left ventricular filling pressures.

Authors:  Sorel Goland; Sarah Shimoni; Shay Livschitz; Gaby Loutaty; Orli Azulay; Rosa Levy; Avraham Caspi; Alex Arditi
Journal:  J Nucl Cardiol       Date:  2004 May-Jun       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.